TUTIVIA
Live / Applied — Fourth extension granted (statement of use) (as of 25 Sept 2025)
What this means for you
Not registered yet, but its 14 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97590460
- Mark type
- Stylized text
- Filed
- 14 Sept 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of organ transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
- Class 010 — Medical apparatus: Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in organ transplant recipients
- Class 042 — Scientific and technological services: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of organ transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
- Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in organ transplant patients; medical analysis services in the field of organ transplants and organ response
Owner
- Verici DX Plc, Cardiff, GB
- Verici DX Plc, Cardiff, GB
Prosecution history
- 24 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2025 — SOU EXTENSION 4 GRANTED
- 25 Sept 2025 — SOU EXTENSION 4 FILED
- 25 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 3 GRANTED
- 11 Mar 2025 — SOU EXTENSION 3 FILED
- 11 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 2 GRANTED
- 25 Sept 2024 — SOU EXTENSION 2 FILED
- 25 Sept 2024 — SOU TEAS EXTENSION RECEIVED